维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="Ribrag"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Glutathione system, topoisomerase Ⅱ level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse显示文摘	Massad - Massade L Ribrag V Marie JP	1997	Anticancer Res1997，17，6：	1
2	Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx显示文摘	Ribrag V Ell Hajj M Janot F	2001	Leukemia2001，15，7：	1
3	Primary breast lymphomas report of 20 case显示文摘	Ribrag V Bibean F El WA	2001	Br J Haemotol2001，115，2：	1
4	PD-1 blockade with the rnonoclonal antibody pembrolizumab (MK-3475) in patients with classical hodgkin lymphoma after brentuximab vedotin failure: pre- liminary results from a phase lb study (KEYNOTE-013)显示文摘	Moskowitz CH Ribrag V Michot J	2014	Blood2014，124，21：	1
5	Early locoregional highdose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx显示文摘	Ribrag V Ell Hajj M Janot F	2001	Leukemia2001，15，7：	1
6	Prospective study of bone marrow in filtration in aggressive lymphoma by three independent methods: Wholebody MRI,PET/CT and bone marrow biopsy显示文摘	Ribrag V Vanel D Leboulleux S	2008	Eut J Radiol2008，66，2：	1
7	Primary breast lymphoma: areport of 20 cases显示文摘	Ribrag V Bibeau F E1 WA	2001	Br J Haematol2001，115，2：	1
8	Early locoregional highdose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx显示文摘	Ribrag V Ell Hajj M Janot F	2001	Leukemia2001，，15：	1
9	CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma:a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte显示文摘	Delarue R Haioun C Ribrag V	2013	Blood2013，121，1：	1
10	CHOPand DHAP plus rituximab followed by autologousstem cell transplantation in mantlecell lymphoma: a phase 2 study from theGroupe dtude des Lymphomes de l'Adulte显示文摘	Delarue R Haioun C Ribrag V	2013	Blood2013，，：	1
11	Phase I study assessing the safety and tolerability of barasertib (AZDl152) with low-dose cytosine arabinoside in elderly patients with AML 显示文摘	Kantarjian HM Sekeres MA Ribrag V	2013	Clin Lympho- ma Myeloma Leuk2013，13，5：	1
12	Early locoregional high-dose radiotherapy is associated with long-term disease control inlocalized primary angiocentric lymphoma of the nose and nasopharynx显示文摘	Ribrag V Ell Hajj M Janot F	2001	Leukemia2001，15，：	1
13	Treatment of youn- ger patients with mantle cell lymphoma显示文摘	Harel S Delarue R Ribrag V	2011	Semin Hematol2011，48，3：	1
14	Safety and efficacy of Abexinostat, a Pan-Histone Deacetylase (HDAC) inhibitor, in non-Hodgkin lymphoma arid chronic lymphocytic leukemia: Results of an ongoing phase 2 study 显示文摘	Ribrag V Kim WS Bouabdallah R	2015	Blood2015，126，23：	1
15	Early Iocoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx显示文摘	Ell HM Janot F	2001	Leukemia2001，15，7：	1
16	Acute tumor lysis syndrome:update on therapy显示文摘	Jabbour E Ribrag V	2005	Rev Med Interne2005，26，：	1
17	Primary breast lymphoma: a report of 20 cases显示文摘	Ribrag V Bibeau F El Weshi A	2001	Br J Haematol2001，115，2：	1
18	Prognostic value of GST-p expression in diffuse large B-cell lymphomas显示文摘	Ribrag V Koscielny S Carpiuc I	2003	Leukemia2003，17，：	1
19	Turnout growth rates and RECIST criteria in early drug development 显示文摘	Gomez-Roca C Koscielny S Ribrag V i	2011	Eur J Cancer2011，47，17：	1
20	Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide,doxorubicin,vincristine,and prednisone plus bortezomib in patients with B-cell lymphoma:a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA)显示文摘	Ribrag V Gisselbrecht C Haioun C		0，，19：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示